CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 568 enrolled
Drug / intervention
bromfenac ophthalmic solutiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00585975
NCT00585975Phase 2Completed
CompareCT.gov

Efficacy and Safety of Bromfenac Ophthalmic Solution

Bausch & Lomb Incorporated·interventional·Posted Jan 4, 2008·Updated Feb 15, 2013

In Brief

A Phase 2 clinical trial evaluating bromfenac ophthalmic solution for Cataract Surgery. Completed, enrolled 568 participants across 1 site.

Detailed Summary

This is a safety and efficacy study of bromfenac ophthalmic solution

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract Surgery
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 4, 2008
Enrollment StartOct 1, 2007
Primary CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 18.5 years ago

Interventions

bromfenac ophthalmic solutiondrug

sterile opthalmic solution